Laparoscopic assessment of epithelial ovarian cancer staging and standardized precision treatment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048593

Enrollment

Unknown

Registered

2021-07-11

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epithelial ovarian cancer

Interventions

Gold Standard:rate of optimal cytoreduction (residue tumor size<1cm)

Index test:laparoscopic&#32

score&#32

based&#32

on&#32

Fagotti

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The pathological type is epithelial ovarian cancer, and the pathological diagnosis has been confirmed by the pathology department; 2. The patients did not receive chemotherapy before enrollment; 3. Have complete follow-up data.

Exclusion criteria

Exclusion criteria: 1. Combined with other malignant tumor diseases; 2. Patients with serious medical diseases.

Design outcomes

Primary

Measure	Time frame
rate of optimal cytoreduction ;	—

Countries

China

Contacts

Public ContactHua Keqin

Obstetrics and Gynecology Hospital of Fudan University

huakeqin@126.com+86 15921515900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026